Additionally, it will be useful to examine if the primacy of the immune system in disease initiation that we describe in this study is specific to the LRRK2 mutations or if this a commonality to other familial PD genes that are shown to be “risk factors” rather than direct drivers of the disorder. The gene discussed is LRRK2; the disease is Parkinson disease.